NCT04031079 is a NA clinical trial of Wearable tech with feedback in Obesity, sponsored by Norwegian University of Science and Technology.

Who is sponsoring NCT04031079?

NCT04031079 is sponsored by Norwegian University of Science and Technology.

What drugs are being tested in NCT04031079?

Interventions in NCT04031079: Wearable tech with feedback, Wearable tech without feedback, Rehabilitation program.

What condition does NCT04031079 study?

NCT04031079 studies Obesity, Overweight.

Is NCT04031079 still recruiting?

NCT04031079 is currently completed. Last updated 27 January 2020.

Last reviewed 2020-01-27 · How we verify

NCT04031079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Wearable Tech to Increase Physical Activity in Inpatient Rehabilitation for Overweight and Obese Patients

Completed NA Last updated 27 January 2020

What this trial tests

NA trial testing Wearable tech with feedback in Obesity in 37 participants. Completed in 13 January 2020.

Timeline

12 August 2019

Primary endpoint
13 January 2020

13 January 2020

Quick facts

Lead sponsor	Norwegian University of Science and Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	37
Start date	12 August 2019
Primary completion	13 January 2020
Estimated completion	13 January 2020
Sites	1 location across Norway

Drugs / interventions tested

Wearable tech with feedback
Wearable tech without feedback
Rehabilitation program

Conditions studied

Obesity — all drugs for Obesity →
Overweight — all drugs for Overweight →

Sponsor

Norwegian University of Science and Technology

Who can join

18 and older, any sex, with Obesity or Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to evaluate whether use of wearable tech increases physical activity in patients participating in inpatient rehabilitation for overweight and obesity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Wearable tech with feedback

Trials testing the same drug.

NCT04031092 — Use of Wearable Tech to Increase Physical Activity in Inpatient Rehabilitation for Patients With Chronic Pain · NA · completed

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Norwegian University of Science and Technology trials

Trials by the same sponsor.

NCT07521891 — Socket-leg Interface Movements in Transtibial Amputees · NA · not yet recruiting
NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting
NCT07422597 — Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost · NA · recruiting
NCT06558851 — The Effect of Systematic Endurance Training in Treatment of Women With Lipedema · NA · active not recruiting
NCT06893874 — A Pragmatic Trial of Machine Prescription for Migraine · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04031079 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian University of Science and Technology
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04031079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing